PEARSON PLC ORD 25P  PSON.L 
$1,028.00  $2.00  0.19%  
DIAGEO PLC ORD 28 101/108P  DGE.L 
$2,515.27  $18.77  0.75%  
RECKITT BENCKISER GROUP PLC ORD  RKT.L 
$4,459.64  $33.36  0.74%  
LLOYDS BANKING GROUP PLC ORD 10  LLOY.L 
$58.77  $0.8888  1.49%  
MELROSE INDUSTRIES PLC ORD GBP0  MRO.L 
$549.40  $6.80  1.22%  
FRESNILLO PLC ORD USD0.50  FRES.L 
$587.00  $20.00  3.29%  
NATWEST GROUP PLC ORD 107.69P  NWG.L 
$331.10  $6.40  1.90%  
WEIR GROUP PLC ORD 12.5P  WEIR.L 
$1,864.00  $49.00  2.56%  
STANDARD CHARTERED PLC ORD USD0  STAN.L 
$703.60  $17.80  2.47%  
ENDEAVOUR MINING PLC ORD USD0.0  EDV.L 
$1,735.00  $71.00  3.93%  
OCADO GROUP PLC ORD 2P  OCDO.L 
$413.04  $1.94  0.47%  
ANGLO AMERICAN PLC ORD USD0.549  AAL.L 
$2,211.00  $11.00  0.50%  
ASHTEAD GROUP PLC ORD 10P  AHT.L 
$5,104.00  $138.00  2.63%  
SEGRO PLC ORD 10P  SGRO.L 
$891.78  $9.42  1.05%  
BAE SYSTEMS PLC ORD 2.5P  BA.L 
$1,232.00  $27.50  2.18%  
VODAFONE GROUP PLC ORD USD0.20   VOD.L 
$69.16  $1.28  1.82%  
HSBC HOLDINGS PLC ORD $0.50 (UK  HSBA.L 
$652.75  $10.25  1.55%  
GLENCORE PLC ORD USD0.01  GLEN.L 
$425.45  $7.90  1.82%  
ROLLS-ROYCE HOLDINGS PLC ORD SH  RR.L 
$431.00  $12.90  2.91%  
UNITE GROUP PLC ORD 25P  UTG.L 
$910.00  $12.00  1.30%  
ANTOFAGASTA PLC ORD 5P  ANTO.L 
$1,896.00  $50.00  2.57%  
CRODA INTERNATIONAL PLC ORD 10.  CRDA.L 
$3,996.00  $63.00  1.55%  
KINGFISHER PLC ORD 15 5/7P  KGF.L 
$271.00  $6.50  2.34%  
SPIRAX GROUP PLC ORD 26 12/13P  SPX.L 
$8,555.00  $75.00  0.87%  
TAYLOR WIMPEY PLC ORD 1P  TW.L 
$153.55  $3.05  1.95%  
WPP PLC ORD 10P  WPP.L 
$721.80  $19.60  2.64%  
RIO TINTO PLC ORD 10P  RIO.L 
$4,887.50  $50.00  1.01%  
HOWDEN JOINERY GROUP PLC ORD 10  HWDN.L 
$908.00  $39.50  4.17%  
MONDI PLC ORD EUR 0.22  MNDI.L 
$1,533.00  $21.00  1.35%  
HARGREAVES LANSDOWN PLC ORD 0.4  HL.L 
$1,090.50  $5.50  0.50%  
BARRATT DEVELOPMENTS PLC ORD 10  BDEV.L 
$500.06  $6.54  1.29%  

iCAD and Google Health announce strategic development and commercialization agreement to integrate AI

Google Health AI and Cloud technology to be integrated into iCAD’s portfolio with the potential to elevate performance and increase access to millions of women around the world.

by The Business Pinnacle
0 comment

The agreement indicates Google Health’s first collaboration with a mammography AI vendor

iCAD Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, on Monday announced a strategic development and commercialization agreement with Google Health to integrate its artificial intelligence (AI) technology into the portfolio of iCAD’s breast imaging AI solutions.

Google Health has entered to introduce its breast imaging AI into clinical practice, marking the first commercial partnership. Both companies will work together to enhance ICAD’s preeminent breast cancer AI solutions for mammography and increase access to the technology for millions of women and providers around the world. iCAD will also leverage Google Cloud’s reliable, scalable infrastructure, accelerating the point in time to market for iCAD’s cloud-held offerings.

Through this partnership, Google has licensed its mammography AI technology and personalized risk assessment with iCAD. iCAD will apply the licensed technology to further improve its 2D and 3D AI algorithms and will commercialize advanced products.

Partnering with Google marks a historic milestone for iCAD, as leveraging Google’s exceptional AI and Cloud technology elevates the caliber of its industry-leading breast AI technologies and may also accelerate adoption and expand access on a global scale, said Stacey Stevens, President, and CEO at iCAD.

Google Health is iCAD’s cross-company initiative to use technology to help everyone, everywhere to be healthier, and collaborating with state-of-the-art companies like iCAD is a key part of this strategy, said Greg Corrado, Distinguished Scientist / Senior Research Director, Google AI.

Google Health’s AI tech may be used to make healthcare more accessible, more open, and more accurate. The entire network needs to work together to expand healthcare solutions that indeed improve service to patients, doctors, and health systems, Corrado stated.

Google Health working with iCAD is an excellent illustration of two organizations partnering to leverage their common forces, technological capabilities, and resources to enhance breast cancer screening worldwide, with the ultimate objective of improving the health outcomes of individuals and communities, Corrado added.

Advancing innovation through partnership

iCAD’s Breast AI Suite is a wide-ranging portfolio of clinically proven technologies for breast cancer detection, density assessment, and individualized short-term risk evaluation.

Through this partnership, iCAD will validate and integrate Google Health’s mammography AI technology into its Breast AI Suite, to maintain patients’ cancer journeys.

Although 3D mammography is increasing in adoption around the world, in many countries 2D mammography remains widely prevalent for breast cancer screening, said Axel Gräwingholt, Head of the Department of Mammography Screening at the Radiologie Am Theater in Paderborn, Germany.

A growing body of research shows ProFound AI could play a significant role in empowering clinicians to overcome these challenges, and iCAD’s commitment to the continual advancement of this technology offers clinicians significant tools that can lead to enhanced outcomes for all, Gräwingholt said.

iCAD also plans to incorporate Google Health’s mammography AI technology into ProFound AI Risk, the world’s first clinical decision support tool that offers an accurate short-term breast cancer risk assessment that is truly tailored for each individual. This is the only commercially available technology that can prospectively detect people who are at a high risk of being diagnosed with breast cancer before or at their next screening, using information readily available in a screening mammogram. It offers clinicians significant information that can support them customize screening regimens for patients, based on their risk, rather than a single-size-fits-all age-based screening program which is the situation in several countries.

Expanding access by cloud-based offerings

In addition to licensing Google Health’s mammography AI technology, iCAD will also leverage Google Cloud’s secure, scalable infrastructure to embark on transforming its delivery model from an on-premises suite of solutions to cloud-hosted solutions. The capability to develop cloud-hosted solutions in different regions can facilitate business-scale access to AI-based tools in underserved regions that are hindered by infrastructure challenges.

Google Cloud presently supports a wide variety of healthcare systems and workflows, to enable secure, unceasing patient care, empower healthcare professionals with partnership and productivity tools, and make better clinical and operational decisions based on data analytics and acumens. By integrating with Google Cloud, iCAD businesses will be able to deploy and scale iCAD’s solutions more seamlessly, extending incomparable interoperability and the potential to increase access on a global scale.

“With customers in over 200 countries and territories worldwide, Google Cloud is used extensively across an array of industries, and it is particularly well optimized for healthcare imaging AI delivery. This partnership will improve its ability to expand its addressable market and accelerate the commercialization of its cloud offering, said Ms. Stevens.

Healthcare providers are gradually shifting away from locally deployed systems in favor of virtual or remote locations. Additionally, hospitals are under increasing pressure to reduce costs, while providing higher-quality care, underscoring the need to streamline operations and increase clinician productivity. Integrating Google’s Cloud technology into this more flexible delivery model offers facilities the solution they need, and the technology patients deserve, Ms. Stevens added.

About iCAD, Inc.

iCAD, Inc., headquartered in Nashua, New Hampshire, is a global medical technology leader providing innovative cancer detection and therapy solutions.

About Google Health

Google Health is an enterprise-wide endeavor to help billions of people be healthier. It works toward this vision by meeting people in their everyday moments and empowering them to remain healthy and uniting with care teams and the public health community to provide more accessible, accurate, and equitable care. The teams are applying their expertise and technology to improve health outcomes globally – with high-quality information and tools to support people manage their health and well-being, solutions to transform care delivery, research to catalyze the use of artificial intelligence for the screening and diagnosis of disease and data and acumens to the public health community.

You may also like

Leave a Comment

Subscribe to Our Newsletters

We are a UK-based business awards firm that specializes in recognizing and celebrating exceptional achievements across various sectors. Our team of experts is dedicated to delivering world-class services, including event management, judging, and award design. With a focus on quality and excellence, we aim to showcase the best of international businesses and inspire future success.

Contact us: [email protected]

© 2022 – The Business Pinnacle. All Right Reserved. Developed by Aapta

The Business Pinnacle